Atara Biotherapeutics (NASDAQ:ATRA) Upgraded by StockNews.com to Hold
StockNews.com upgraded shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) from a sell rating to a hold rating in a report published on Thursday. Separately, HC Wainwright reaffirmed a buy rating and issued a $28.00 price target on shares of Atara Biotherapeutics in a research note on Tuesday, September 26th. Check Out Our Latest Report […]
More Stories
Neuberger Berman High Yield Strategies Fund Inc. (NYSEAMERICAN:NHS) Plans $0.09 Monthly Dividend
Neuberger Berman High Yield Strategies Fund Inc. (NYSEAMERICAN:NHS – Get Free Report) announced a monthly dividend on Tuesday, December 31st,Wall...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...